Loureiro, Liliana R.
Feldmann, Anja
Bergmann, Ralf
Koristka, Stefanie
Berndt, Nicole
Máthé, Domokos
Hegedüs, Nikolett
Szigeti, Krisztián
Videira, Paula A.
Bachmann, Michael
Arndt, Claudia
Article History
Received: 4 February 2020
Accepted: 15 April 2020
First Online: 5 May 2020
Ethics approval and consent to participate
: All animal procedures were conducted in accordance with the ARRIVE guidelines and the guidelines set by the European Communities Council Directive (86/609 EEC). The local Ethical Committee for Animal Experiments approved the animal facilities and the protocol according to institutional guidelines at the Semmelweis University approved by the Workplace Animal Ethical Committee (MÁB).
: Not applicable.
: LRL, PAV and MB have filed patents related to anti-STn mAb L2A5. MBP has filed patents related to the UniCAR system. MB is shareholder of the company GEMoaB which owns the IP related to the UniCAR system. The other authors declare that they have no competing interests.